Remove Healthcare Remove Pharmaceutical Remove Safety Remove Side effects
article thumbnail

UK agency pilots biobank to study links between genetics and drug side effects

Pharmaceutical Technology

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. According to the press release, the MHRA will be the first drug safety regulator in the world to pilot such a biobank.

article thumbnail

From Classroom to Virtual Reality: How Pharmaceutical Rep Training Has Evolved

Contrarian Sales Techniques

When I first started as a pharmaceutical sales rep a decade ago, training was a rigorous but straightforward affair. We were drilled on the science behind our medications, their benefits, potential side effects, and the competitive landscape. Back then, training was heavily focused on product knowledge.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Navigating the Regulatory Environment of Pharmaceutical Marketing: Balancing Patient Safety and Industry Innovation

Pharma Marketing Network

Pharmaceutical marketing is a critical aspect of the industry, as it helps in spreading awareness about the benefits and potential side effects of different drugs. However, pharmaceutical marketing is also regulated by several agencies to ensure that patients are not exposed to false or misleading information.

Safety 52
article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. They detail the medication’s intended use, proper administration, potential side effects and precautions. percent as EU average with some Member States as high as 25 percent).

article thumbnail

UK MHRA approves Pfizer-BioNTech’s bivalent Covid-19 booster

Pharmaceutical Technology

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Pfizer and BioNTech’s bivalent Covid-19 booster vaccine that targets the SARS-CoV-2 virus’ original strain and the Omicron BA.4 1 vaccine as well as the safety results from a clinical trial underway. 5 sub-variants.

article thumbnail

My Journey as a Pharmaceutical Sales Rep: The Importance of Product Knowledge and Accurate Information

Contrarian Sales Techniques

When I first started working as a pharmaceutical sales representative, I didn't fully understand the importance of product knowledge and accurate information. As a pharmaceutical sales representative, I have received extensive training on the products I represent. But product knowledge is not the only important aspect of my job.

article thumbnail

First CRISPR-based gene-editing therapy authorised

European Pharmaceutical Review

It has been conditionally authorised by the UK Medicines and Healthcare products Regulatory Agency (MHRA) as a gene-editing therapy for certain patients 12 years old and over with sickle-cell disease and transfusion-dependent β-thalassemia. Side effects from treatment were similar to those associated with autologous stem cell transplants.

Safety 95